ArticleFocus (American Psychiatric Publishing)2013
Depression in Late-Life: a Focus on Prevention.
Article in Focus (American Psychiatric Publishing), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Does retirement trigger depressive symptoms? A systematic review and meta-analysis.Epidemiology and psychiatric sciences · 2021Pooled it
- Effects of Vitamin DThe Journal of clinical psychiatry · 2023Trial
- Speed of processing training and depression in assisted and independent living: A randomized controlled trial.PloS one · 2019Trial
- Prevention of late-life depression: a framework and prospectus for research.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Review
- Public Health Perspectives of Geriatric Mental Health Care.Indian journal of psychological medicine · 2021Article
- Observational
- Pilot study of DNA methylation, molecular aging markers and measures of health and well-being in aging.Translational psychiatry · 2019Article
- Aging and well-being in Goa, India: a qualitative study.Aging & mental health · 2018Article
- Design and Rationale for a Technology-based Healthy Lifestyle Intervention in Older Adults Grieving the Loss of a Spouse.Contemporary clinical trials communications · 2017Article
- Self-management in epilepsy: Why and how you should incorporate self-management in your practice.Epilepsy & behavior : E&B · 2017Article
- Biological Aging and the Future of Geriatric Psychiatry.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017Review
- The role of vitamin D in the prevention of late-life depression.Journal of affective disorders · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Depression is a leading cause of disease burden, disability and distress for millions of older adults. Thus, prevention of late-life depression is a priority research area. This article addresses the science of late-life depression prevention with the following: 1) an introduction to the Institute of Medicine framework of universal, selective and indicated prevention as it pertains to late-life depression, with particular attention to successes of indicated and selective prevention in primary care; 2) a discussion of how biomarkers can be integrated into prevention research, using interferon-alpha-induced depression as a model; 3) an outline for expansion of prevention to non-specialist care delivery systems in Low and Middle Income Countries - thus, extending the reach of current successful approaches; 4) a description of a novel approach to simultaneous testing of universal, selective and indicated prevention in late-life depression, with emphasis on study design features required to achieve practical, scalable tests of health impact.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.